Release Date: November 30, 2012
The purpose of this Notice is to inform NCCAM grant applicants that, beginning with applications submitted for the January 25, 2013 submission date and beyond, NCCAM support of investigator-initiated clinical trials that study an intervention delivered to human subjects will be limited to studies carried out within the United States and Canada, except in special settings described in this policy statement (http://nccam.nih.gov/grants/internationalclinicaltrials).
NCCAM will continue to support highly meritorious international grants that propose non-interventional, observational, or epidemiologic clinical studies, as well as basic mechanistic and non-clinical translational research.
All investigators interested in support of international research by NCCAM should contact the appropriate NCCAM Program Officer (http://nccam.nih.gov/grants/contact) to discuss eligibility and options.
Please direct all inquiries to:
John Williamson, Ph.D.
National Center for Complementary and Alternative Medicine (NCCAM)
6707 Democracy Blvd, Suite 401
Bethesda, MD 20892-5475
Telephone: (301) 301-496-2583
Fax: (301) 301-480-1581